市場調査レポート

商品コード

1566184

顔用注射剤の市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業予測、2024年～2031年

Facial Injectables Market Size, Share, Growth Analysis, By Product (Collagen & PMMA Microspheres, Hyaluronic Acid ), By Application, By End-use, By Region - Industry Forecast 2024-2031

出版日: 2024年10月01日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 800,088円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 935,952円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,071,816円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.96円

全表示
概要
目次

概要

サンプル依頼リストに入れる

顔用注射剤の世界市場規模は、2022年に101億米ドルと評価され、2023年の113億1,000万米ドルから2031年には280億1,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは12.00%で成長する見通しです。

顔用注射剤の世界市場は、顔面美容強化の需要増に牽引され、今後数年間で大幅な成長を遂げるでしょう。この分野は、美容治療のために特別に設計された注射用物質の生産、流通、応用を包含し、主にしわを減らし、顔のボリュームを回復させ、全体的な肌の外観を改善するアンチエイジング・ソリューションに焦点を当てています。この市場は主に、ボツリヌス毒素注射と皮膚フィラーという2つの主要な手法を中心に展開されており、どちらも肌のツヤと保湿を高め、キメの改善につながるものです。顔用化粧品に対する消費者の関心が高まるにつれ、若年層の可処分所得の急増と相まって、美容・化粧品への支出はプラスに転じると予想されます。特筆すべきは、米国の顔用注射剤市場は、今後の予測期間において持続可能な複合年間成長率（CAGR）を達成すると予測されていることであり、これは消費者の美容動向への関与の増加という広範な傾向を反映しています。外見とセルフケアを重視する社会的傾向が強まっていることから、顔用注射剤市場は継続的な拡大が見込まれ、美容・ウェルネス産業における投資とイノベーションの重要な分野となっています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Ispen（France）
Abbvie（US）
Medytox Inc.（South Korea）
Merz GmbH and Co. KGaA（Germany）
Revance Therapeutics, Inc.（US）
Galderma（Switzerland）
Sinclair Pharma（UK）
Allergan Aesthetics（a subsidiary of AbbVie）（US）
Hugel, Inc.（South Korea）
Sientra, Inc.（US）
Revance Therapeutics, Inc.（US）
Evolus, Inc.（US）
Medytox Inc.（South Korea）
Hugel, Inc.（South Korea）
AptarGroup, Inc.（US）
Ipsen S.A.（France）
Galderma S.A.（Switzerland）
Revanesse（Canada）
Merz North America（US）
Suneva Medical, Inc.（US）
Aesthetic Medical International Holdings Group（China）
Neauvia（Switzerland）

Product Code: SQMIG35I2287

Global Facial Injectables Market size was valued at USD 10.1 billion in 2022 and is poised to grow from USD 11.31 billion in 2023 to USD 28.01 billion by 2031, growing at a CAGR of 12.00% during the forecast period (2024-2031).

The global facial injectables market is set for substantial growth in the coming years, driven by an increasing demand for facial aesthetic enhancements. This sector encompasses the production, distribution, and application of injectable substances specifically designed for aesthetic treatments, primarily focusing on anti-aging solutions that reduce wrinkles, restore facial volume, and improve overall skin appearance. The market primarily revolves around two key methodologies: botulinum toxin injections and dermal fillers, both of which enhance skin glow and moisture retention, leading to improved texture. As consumer interest in facial cosmetics rises, coupled with a surge in disposable income among younger demographics, spending on beauty and cosmetic products is expected to see a positive uptick. Notably, the U.S. facial injectables market is anticipated to achieve a sustainable compound annual growth rate (CAGR) in the upcoming forecast period, reflecting the broader trend of increased consumer engagement with aesthetic treatments. The growing societal emphasis on appearance and self-care is further positioning the facial injectables market for continued expansion, making it a key area for investment and innovation within the beauty and wellness industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Facial Injectables market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Facial Injectables Market Segmental Analysis

Global Facial Injectables Market is segmented by Product, Application, End-use and region. Based on component, the market is segmented into Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), and Others. Based on Application, the market is segmented into Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Others. Based on End-use, the market is segmented into MedSpas, Dermatology Clinics, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Facial Injectables Market

The Global Facial Injectables market is poised for substantial growth, driven by the escalating consumer demand for non-invasive aesthetic solutions, particularly among the Millennial demographic, who increasingly favor facial injectables to address skin damage caused by environmental factors and lifestyle choices. With products like collagen fibers, hyaluronic acid fillers, and synthetic injectables, consumers are attracted to the dual benefits of hydration and UV protection, alongside minimal side effects. Additionally, rising disposable incomes and advancements in technology, which enhance safety by reducing infection risks and procedure costs, are further fueling the market's expansion during the forecast period.

Restraints in the Global Facial Injectables Market

The Global Facial Injectables market faces several market restraints that limit its expansion. Stringent regulatory requirements and limitations concerning product approval create barriers to entry and complicate the commercialization of new solutions. Additionally, skin-related side effects such as rashes and redness discourage potential consumers from seeking these treatments, especially as safety concerns grow. High costs associated with fillers can also deter patients from opting for facial injectables, while the lack of insurance coverage for aesthetic procedures further exacerbates the issue, restricting market growth. Together, these factors create a challenging environment for the advancement of the global facial injectables industry.

Market Trends of the Global Facial Injectables Market

The Global Facial Injectables market is witnessing a significant trend fueled by the rising acceptance of these cosmetic treatments among the male population. As more men seek anti-aging solutions, the adoption of dermal fillers and botulinum toxin is on the rise, reflecting a shift in societal norms around male aesthetics. Young males, in particular, are increasingly inclined towards tissue fillers for rejuvenation purposes, further driving this trend. Additionally, hyaluronic acid fillers are gaining traction due to their efficacy in anti-aging treatments, propelling market growth. This evolving landscape indicates a broader demographic embracing facial injectables, expanding the market's potential.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Facial Injectables Market by Product

Market Overview
Collagen & PMMA Microspheres
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Poly-L-lactic Acid (PLLA)
Others

Facial Injectables Market by Application

Market Overview
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Others

Facial Injectables Market by End-use

Market Overview
MedSpas
Dermatology Clinics
Hospitals

Facial Injectables Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Ispen (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbvie (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medytox Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz GmbH and Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revance Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinclair Pharma (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan Aesthetics (a subsidiary of AbbVie) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hugel, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sientra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revance Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evolus, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medytox Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hugel, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AptarGroup, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ipsen S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galderma S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revanesse (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz North America (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suneva Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aesthetic Medical International Holdings Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neauvia (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

顔用注射剤の市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業予測、2024年～2031年

Facial Injectables Market Size, Share, Growth Analysis, By Product (Collagen & PMMA Microspheres, Hyaluronic Acid ), By Application, By End-use, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

顔用注射剤市場：製品別

顔用注射剤市場：用途別

顔用注射剤市場：最終用途別

顔用注射剤市場規模：地域別